ADT Inc. Announces Dividend Reinvestment Plan BOCA RATON,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
21
ADT Inc. Announces Dividend Reinvestment Plan

BOCA RATON, Fla., March 22, 2019 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), a leading provider of security and automation solutions in the United States and Canada, today announced that its stockholders will have an opportunity to participate in its Dividend Reinvestment Plan (the “Plan”). The Company has adopted the Plan to provide stockholders of record on the applicable record date with the opportunity to designate all or a portion of the cash dividends they are entitled to receive on their shares of common stock for reinvestment in additional shares of the Company’s common stock.

Initially, the Company will issue the shares under the Plan directly at no discount to the volume weighted average closing trading price per share of the Company’s common stock for the five (5) trading days preceding the dividend payment date with respect to the common stock and without incurring brokerage fees or commissions. The maximum number of shares of common stock that may be issued under the Plan is 18,750,000 shares (subject to increase from time to time by the board of directors) and the Plan will be in effect until February 27, 2021 unless earlier suspended or terminated by the board of directors.

Participation in the Plan is optional; stockholders who do not elect to participate in the Plan will receive a cash dividend. Dividends are payable only as and when declared by the board of directors.

As recently announced on March 11, 2019, the Company’s board of directors declared a cash dividend of $0.035 per share which will be paid on April 12, 2019 to stockholders of record as of the close of business on April 2, 2019. Stockholders must enroll in the Plan by 5:00 pm (ET) on the record date for these dividends to qualify for participation in the Plan.

The Plan will be administered through the Company’s stock transfer agent, American Stock Transfer & Trust Company (“AST”). Stockholders and other persons may obtain enrollment forms by contacting AST at (800) 937-5449 or online through www.astfinancial.com . Stockholders may also enroll by completing an enrollment form and mailing it to American Stock Transfer & Trust Company, LLC, P.O. Box 922, Wall Street Station, New York, New York 10269-0560, Attn: Plan Administration Department. To participate in the Plan, for this dividend or for any future dividend, if any, eligible stockholders must complete and submit and an enrollment form before 5:00 pm (ET) on the applicable record date.

Stockholders should review the Plan prospectus prior to enrolling. Copies of the Plan prospectus are available online at AST’s website, https://us.astfinancial.com/InvestOnline/Invest/AllPlan , or by calling AST at (800) 278-4353.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities. The offer is being made solely through the Plan prospectus, which was filed with the Securities and Exchange Commission and is available on the Securities and Exchange Commission’s website at www.sec.gov .

About ADT ADT  is a leading provider of security and automation solutions in the United States and Canada, protecting homes and businesses, people on-the-go and digital networks. Making security more accessible than ever before, and backed by 24/7 customer support, ADT is committed to providing superior customer service with a focus on speed and quality of responsiveness, helping customers feel safer and empowered. ADT is headquartered in Boca Raton, Florida and employs approximately 19,000 people throughout North America.

Forward-Looking Statements

ADT has made statements in this press release and other reports, filings, and other public written and verbal announcements that are forward-looking and therefore subject to risks and uncertainties.  All statements, other than statements of historical fact, included in this document are, or could be, “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are made in reliance on the safe harbor protections provided thereunder.  These forward-looking statements relate to anticipated financial performance, management’s plans and objectives for future operations, business prospects, outcome of regulatory proceedings, market conditions and other matters.  Any forward-looking statement made in this press release speaks only as of the date on which it is made.  ADT undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise.  Forward-looking statements can be identified by various words such as “expects,” “intends,” “will,” “anticipates,” “believes,” “confident,” “continue,” “propose,” “seeks,” “could,” “may,” “should,” “estimates,” “forecasts,” “might,” “goals,” “objectives,” “targets,” “planned,” “projects,” and similar expressions.  These forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to management.  ADT cautions that these statements are subject to risks and uncertainties, many of which are outside of ADT’s control, and could cause future events or results to be materially different from those stated or implied in this document, including among others, risk factors that are described in the Company’s Annual Report on Form 10-K and other filings with the Securities and Exchange Commission, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained therein.

Investor Relations: Jason Smith – ADT investorrelations@adt.com

Media Relations Mónica Talán tel: +1 561.613.2331 mtalan@adt.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading